AIMed Clinician Series returns
The critically acclaimed series is back with a fresh new format.
The critically acclaimed series is back with a fresh new format.
Multi-hospital initiative sparked by the COVID-19 crisis shows that, by working together, institutions in any industry can develop predictive AI models that set a new standard for both accuracy and generalizability.
Honor bestowed in recognition of lifetime dedication to the advancement of biomedical informatics through both research and education.
The Medicines and Healthcare products Regulatory Agency (MHRA) is updating regulations applying to software and artificial intelligence (AI) as a medical device.
Misconceptions about AI are a common hurdle that can foster resistance and misuse. No matter what science fiction tells us, AI will never replace a clinician’s judgement. Rather, AI should be seen as a clinical decision support tool, much like radiology or laboratory tests.
NHS England programme is one of the first large-scale lung cancer screening initiatives substantially supported by AI.
“The mission of AIMed is fully aligned with our mission in healthcare. We both wish to create efficient workspaces for clinicians with advancing patient outcomes at its core.”
Advancements in AI and voice technology mean clinicians now have access to a secure tool that can help reduce admin by up to an hour a day and save hundreds of pounds in related data entry costs.
We didn’t always get it right. We attributed illness and disease to supernatural causes. Then, for a while, we considered the four humours responsible for most illnesses. We would alter the temperature of the diet, give laxatives, or drain the patient’s blood to restore balance to the humours.